Cargando…
Combination Immunosuppressive Therapy Including Rituximab for Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis in Adult-Onset Still's Disease
Hemophagocytic lymphopcytosis (HLH) is a life-threatening condition. It can occur either as primary form with genetic defects or secondary to other conditions, such as hematological or autoimmune diseases. Certain triggering factors can predispose individuals to the development of HLH. We report the...
Autores principales: | Schäfer, Eva Johanna, Jung, Wolfram, Korsten, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5149644/ https://www.ncbi.nlm.nih.gov/pubmed/28018698 http://dx.doi.org/10.1155/2016/8605274 |
Ejemplares similares
-
Epstein–Barr Virus and Hemophagocytic Lymphohistiocytosis
por: Marsh, Rebecca A.
Publicado: (2018) -
Epstein-Barr Virus-Induced Hemophagocytic Lymphohistiocytosis
por: Goudarzipour, K., et al.
Publicado: (2013) -
Epstein–Barr virus infection–Related hemophagocytic lymphohistiocytosis
por: Kumar, Navin, et al.
Publicado: (2015) -
Epstein-Barr Virus Infection-associated Hemophagocytic Lymphohistiocytosis
por: Contreras-Chavez, Pamela, et al.
Publicado: (2020) -
Alternative Therapy for Epstein-Barr Virus Related Hemophagocytic Lymphohistiocytosis
por: Al Asad, Omar, et al.
Publicado: (2015)